It should trade at a higher multiple if they can grow like that for sure.
Including adding back R&D in FY18, they make about 15% EBITDA margin, so if they get to $24m revenue organically in FY20, that would be about $3.6m EBITDA at 10.0x = $36m EV, so about 9.0 cents/share?
I actually think they can achieve better multiples and better financial results if they acquire.
JCurve Solutions (JCS) - Oracle, page-5
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add JCS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
-0.003(12.0%) |
Mkt cap ! $7.223M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.2¢ | $3.359K | 152.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1178898 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 1233502 | 2 |
View Market Depth
| Last trade - 15.45pm 02/08/2024 (20 minute delay) ? |
| JCS (ASX) Chart |